HANALL BIOPHARMA CO.,LTD revenue breakdown overview

HANALL BIOPHARMA CO.,LTD revenue for the last year amounted to 139.00 B KRW, the most of which — 138.94 B KRW — came from its highest performing source at the moment, Pharmaceutical, the year earlier bringing 134.91 B KRW. The greatest contribution to the revenue figure was made by South Korea — last year it brought HANALL BIOPHARMA CO.,LTD 138.94 B KRW, and the year before that — 134.84 B KRW.